Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02738632Phase 3Completed
A Phase 3 trial of telmisartan, amlodipine, hydrochlorothiazide in essential hypertension, sponsored by Ildong Pharmaceutical Co Ltd. Started May 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02738632.